H

Huakang Biomedical Holdings Co Ltd
HKEX:8622

Watchlist Manager
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Watchlist
Price: 0.184 HKD -0.54%
Market Cap: 92.1m HKD
Have any thoughts about
Huakang Biomedical Holdings Co Ltd?
Write Note

Net Margin
Huakang Biomedical Holdings Co Ltd

-24.3%
Current
-18%
Average
2.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-24.3%
=
Net Income
-6.1m
/
Revenue
25.1m

Net Margin Across Competitors

Country HK
Market Cap 92.1m HKD
Net Margin
-24%
Country JP
Market Cap 7T JPY
Net Margin
24%
Country CH
Market Cap 37.8B CHF
Net Margin
11%
Country DK
Market Cap 205.9B DKK
Net Margin
19%
Country US
Market Cap 16.6B USD
Net Margin
11%
Country CN
Market Cap 52.9B CNY
Net Margin
42%
Country CA
Market Cap 6.9B USD
Net Margin
-8%
Country UK
Market Cap 5.1B GBP
Net Margin
7%
Country CH
Market Cap 5.2B CHF
Net Margin
14%
Country US
Market Cap 5.9B USD
Net Margin
9%
Country US
Market Cap 5.6B USD
Net Margin
29%

Profitability Report

View the profitability report to see the full profitability analysis for Huakang Biomedical Holdings Co Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-24.3%
=
Net Income
-6.1m
/
Revenue
25.1m
What is the Net Margin of Huakang Biomedical Holdings Co Ltd?

Based on Huakang Biomedical Holdings Co Ltd's most recent financial statements, the company has Net Margin of -24.3%.